KAPLAN GILLA
SEC Form 4 insider trading activity
KAPLAN GILLA has filed 2 SEC Form 4 filings (5 transaction rows) across 2 companies, including AVTX, TYRA, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Mar 31, 2026.
On the most recent filing, KAPLAN GILLA is listed as Director at Tyra Biosciences, Inc. Inside the rolling window, KAPLAN GILLA reported no open-market purchases and 1 open-market sale totaling $529K in TYRA.
Companies traded
Other insiders at AVTX
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$529K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has KAPLAN GILLA made?
KAPLAN GILLA has filed 2 SEC Form 4 filings (5 transaction rows) across 2 companies, including AVTX, TYRA since 2026.
Which companies does KAPLAN GILLA trade?
KAPLAN GILLA has filed SEC Form 4 disclosures for 2 companies, including AVTX, TYRA.
When was KAPLAN GILLA's most recent SEC Form 4 filing?
KAPLAN GILLA's most recent SEC Form 4 filing on Tracefour is dated Mar 31, 2026.
What is KAPLAN GILLA's total buy and sell value in the current window?
Inside the rolling retention window, KAPLAN GILLA bought $0 and sold $529K based on SEC Form 4 filings.
What was KAPLAN GILLA's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 14,295 TYRA shares on 2026-03-25, worth $529K, per SEC Form 4 filings.